FEB 13, 2016 08:19 AM PST

Bacteria's Killer Trait Becomes New Drug Delivery System

WRITTEN BY: Xuan Pham
R bodies in different states

Imagine a nanoscale needle that can pierce cells precisely and on command. Scientists from Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) have developed just this, possibly revolutionizing the future of drug delivery.
 
Published in the American Chemical Society Synthetic Biology, the discovery adapts bacterial protein polymers known as “R bodies” into precise, retractable nanoneedles. Controlled by pH levels, the nanoneedles extend to puncture cell membranes to release encapsulated cargo. Once pH levels change, they quickly reverse to the coiled form, ready for action yet again.
 
"This is one of nature’s innovations, but the discovery here is our ability to translate this from nature into a system that we can now engineer and control," said Pamela Silver, senior author on the study and Wyss Core Faculty member.
 
In nature, R bodies are produced by the Paramecium endosymbionts as a form of deadly self-defense. R bodies exist as coiled proteinaceous ribbons at low pH. In response to being ingested by another bacterial strain, the “killer strain” uses the differences in pH levels to activate its killer trait – extension of the R bodies – to rupture the host cell’s membrane. Toxins are then released which kills the host paramecium.
 
Impressed by these biological javelins, the research team at Harvard adapted this defense mechanism into a new way to deliver drugs to targeted cells. They expressed and purified the R bodies from E. coli. They then fine-tuned the extension process by screening for mutants that have altered pH sensitivity. Ultimately, they derived at a system of synthetic pistons that respond to pH levels to puncture E. coli membranes, releasing encapsulated cargo.
 
"Our research establishes R bodies as biological machines that we can use to break through membranes,” said Jessica Polka, first author of the study. “These actuators don’t consume molecular fuel and are extremely robust; we believe they could one day be used to deliver material to mammalian cells."
 
The system has many advantages, including its tunable platform, which allows for controlled release of trapped content. The authors see this as a potential way to deliver toxins or other pharmaceutical payloads directly to targeted cells. For cancer, this system could more effectively kill tumor cells and reduce collateral damages to healthy cells.
 
Another property that makes this delivery system quite unique is its reversibility. Because the extension and retraction actions are purely mechanical, they can be controlled with great precision and can be re-used over and over again. This is highly beneficial considering the many compartments that are contained in eukaryotic cells.
 
The sky seems to be the limit for these new biological actuators. “By decorating these polymers with different kinds of metals or other materials with properties of interest, we could potentially develop a range of actuator-like, nanoscale structures," said Silver.
 
"There are so many amazing mechanisms engineered by Nature, and this is a great example of how we can mine living systems for unique biological elements and adapt them to develop programmable technologies for high value applications using synthetic biology," said Donald Ingber, Wyss Institute Founding Director.
 

Additional source: Wyss Institute
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 22, 2018
Cancer
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
MAY 23, 2018
Technology
MAY 23, 2018
Building Block Medical Test Is Reusable
MIT's Little Devices Lab has created a more affordable solution called Ampli blocks that consists of modular diagnostic kits, which can be re-oriented and reused....
JUN 05, 2018
Technology
JUN 05, 2018
Bacteria Capsule Finds Stomach Bleeding, Alerts Smartphone
MIT Smart Bacteria Sensor Hunts for Stomach Bleeding...
JUN 19, 2018
Clinical & Molecular DX
JUN 19, 2018
Three-Dimensional Diagnosis of Osteoarthritis
There is a new way to diagnose arthritis and watch its progression slowly over time to determine the best route of treatment. From the University of Cambri...
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Bubbles and a blood test could detect brain tumors
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple blood test, rather than a complicat...
SEP 17, 2018
Microbiology
SEP 17, 2018
Detecting Dangerous Latent Viruses
Evidence mounts that viruses play a role in disease development....
Loading Comments...